För närvarande är hon aktiv i styrelserna för Praktikertjänst AB, Camurus, Sahlgrenska Science Park, Enzymatica AB, Recipharm och i fullmäktige för Skandia.

Enzymatica har valt en ny mediebyrå i form av Wavemaker Malmö. Därmed förlorar Scream uppdraget.

Enzymatica AB (publ),556719-9244 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Enzymatica AB Stock analysis for Enzymatica AB (ENZY:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Enzymatica AB: Extraordinary shareholders' meeting on changes to the board of directors. Press release Lund, 1 December 2016. Bengt Baron is proposed as new chairman of Enzymatica and Mats K Andersson and Louise Nicolin as new board members. Enzymatica AB: New version - corrected 17 September, 2020 The results of Enzymatica's placebo-controlled, randomized study Stock release 17.09.2020 17:55 Enzymatica distributed the press release about the result from its placebo-controlled, randomized study in Germany on August 17th. GlobeNewswire 4/11/2018 Enzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus.

Produkterna baseras på barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är ColdZyme® Munspray som kan förhindra förkylning, och kan förkorta sjukdomsperioden. Stock analysis for Enzymatica AB (ENZY:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-03-31 Find the latest ENZYMATICA AB (EZYMF) stock quote, history, news and other vital information to help you with your stock trading and investing. 2020-07-20 Enzymatica AB: New version - corrected 17 September, 2020 The results of Enzymatica's placebo-controlled, randomized study Stock release 17.09.2020 17:55 Enzymatica distributed the press release about the result from its placebo-controlled, randomized study in Germany on August 17th.

Första patienterna inkluderade i stor placebokontrollerad multicenterstudie med ColdZyme.

9 Nov 2017 News Lund, November 9, 2017. ColdZyme study - Most recommended cold product at pharmacies. A new market survey shows that

It researches, develops and Enzymatica AB. (ENZY.ST) Reuters news feed 13 Oct 2020 STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- Enzymatica AB and This information was brought to you by Cision http://news.cision.com. Enzymatica AB Aktie: WKN A1WZEV - ISIN SE0003943620 - Aktueller Aktienkurs , Charts, Nachrichten und Termine zu Enzymatica AB. Kallelse till årsstämma 2021 i Enzymatica AB (publ) | Placera. AVANZA. Enzymatica publicerar årsredovisningen för 2020 | Placera https://news.cision.

Enzymatica announces today the preliminary results of an in vitro study showing the ability of the mouth spray ColdZyme® to deactivate SARS-CoV-2, the virus causing the COVID-19 pandemic. The study demonstrated that ColdZyme deactivates SARS-CoV-2 coronavirus by 98.3% (1.76 log10). The results indicate that ColdZyme can offer a protective barrier against harmful viruses such as SARS-CoV-2 by

2021-03-29 · News provided by. Enzymatica AB 29 Mar, 2021, 07:50 BST. Share this article.

The following files are available for Enzymatica Aktie (EN9) Branche: : (WKN: A1WZEV ISIN: SE0003943620 ) ✓ Kurs mit Realtime Chart News zum Wert Kurs zur ENZYMATICA AB Aktie.
Kreditvarderingsforetag

Executive Summary. Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. 11 Feb 2021 Claus Egstrand , Chief Operating Officer Enzymatica AB https://news.cision. com/enzymatica-ab/r/enzymatica-comments-on-article-in-dagens- Enzymatica AB | 857 followers on LinkedIn. Enzymatica is a life science company whose business concept is to offer View all updates, news, and articles.

News provided by. Enzymatica AB 12 Nov, 2020, 15:40 GMT. Share this article. Share this article.
Ingående balans eget kapital

Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer.

The patent includes use of the cod enzyme for treatment and prevention of microbial infections in individuals with immunodeficiency. The patent is valid until 2035. Sandia seeks patent, business partners for new N95 masks. April 18, 2021 at 00:02 am Get the latest Enzymatica AB (ENZY.ST) stock news and headlines to help you in your trading and investing decisions. New strategic recruitments and organizational changes at Enzymatica Fri, Jan 15, 2021 08:30 CET. To support Enzymatica’s growth journey, Enzymatica has hired Malin Richter to serve as Director Operations and Kristoffer Ahlerup as Director Commercial for the Enzymatica Group. 2021-03-29 2021-03-29 2021-03-29 The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing shareholders, by exercising the authorization of a new rights issue from the Annaul General Meeting 2020 (the "Rights issue").The purpose of the Rights issue is above all to enable the Company's offensive As Enzymatica’s international expansion gathers pace, the company has made several organizational changes.

Orezone AB (publ) har av Nordic Growth Market NGM AB; Mazars blir Companies 28, 2019 /PRNewswire/ - Enzymatica and its German its Frankfurt-News: Realtime Kurse der Börse Stuttgart im Push-Chart aktivieren!

AVANZA. Enzymatica publicerar årsredovisningen för 2020 | Placera https://news.cision.com/.

Publicerad 2021-03-22. Enzymatica, -6,46% Aktia Rahastoyhtiö Oy, Aktie-Ansvar, Alcur Fonder AB, Alfakraft Fonder AB, Alfred Berg, Alfred Berg Kapitalforvaltning, ALGER SICAV Enzymatica AB - Cision News Enzymatica aktie — Enzymatica komplett bolagsfakta Enzymatica AB (publ) - : 5567199244. av Á Gudmundsdottir · Citerat av 3 — Enzymatica AB, Lund, Sweden.